Uniphar (UPR.I, UPR ID)

  • 872.3
  • 273.0
  • 95.1

    Closing Price (c): 319.5

  • RATING 27/08/19


Company Profile

Uniphar is a diversified healthcare services business operating across three divisions: Commercial & Clinical (47% of group EBITDA 2022E), Product Access (19%) and Supply Chain & Retail (34%). Structural industry growth, proprietary digital platforms and expansion into new geographies underpin a strong organic growth outlook. There is also meaningful scope for bolt-on M&A, supported by a senior leadership team with deep experience across the healthcare services space. Management aims to double group EBITDA within five years (15% CAGR).

Major Shareholders%
Allianz Global Investors9.0
Polar Capital LLP7.4
Rabbette Gerard2.8
Mackenzie Investments Europe Ltd.2.8
Swedbank Robur Fonder AB2.6